These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8375726)

  • 1. To P32 or not to P32, that is the question.
    Runowicz CD
    Gynecol Oncol; 1993 Aug; 50(2):139-40. PubMed ID: 8375726
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radiation therapy effects in ovarian cancer--review].
    Ito H; Uno T; Kawata T; Isobe K
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():560-4. PubMed ID: 15535308
    [No Abstract]   [Full Text] [Related]  

  • 3. Distant metastases in cases of primary ovarian carcinoma.
    Piatkowski Z
    Pol Med J; 1972; 11(1):147-51. PubMed ID: 5040990
    [No Abstract]   [Full Text] [Related]  

  • 4. Intracavitary use of radioactive colloidal phosphorus 32 in the treatment of epithelial ovarian cancer.
    Saul HM; Sedlacek TV; Heller PB; Glassburn JR; Riva J; Bertoli R; Maslack M; Lin JK
    J Am Osteopath Assoc; 1996 Dec; 96(12):727-32. PubMed ID: 9111774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observations on the interpretation of clinical trials in early ovarian cancer.
    Swart AM; Parmar MK
    J Clin Oncol; 2005 Feb; 23(4):927; author reply 937-8. PubMed ID: 15681549
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant 32P in the treatment of ovarian carcinoma.
    Condra KS; Mendenhall WM; Morgan LS; Marcus RB
    Radiat Oncol Investig; 1997; 5(6):300-4. PubMed ID: 9436247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endoperitoneal radioisotope therapy of malignant epithelial tumors of the ovary].
    Tardy A; Boidi-Trotti A
    Minerva Ginecol; 1984 Apr; 36(4):199-201. PubMed ID: 6462522
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Loculation as a contraindication to intracavitary 32P-chromic phosphate therapy.
    Vider M; Deland FH; Maruyama Y
    J Nucl Med; 1976 Feb; 17(02):150-1. PubMed ID: 1245879
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of ovarian cancer without ascites, using radioactivesuspensions; Study of results analyzed by computer].
    Clode WH; Rodrigues E; Nogueira AR; Baptista AM
    Arq Patol; 1974 Apr; 46(1):89-96. PubMed ID: 4462525
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary cytoreductive surgery for isolated nodal recurrence of ovarian cancer.
    Bristow RE
    Ann Surg Oncol; 2004 Jul; 11(7):639-40. PubMed ID: 15197010
    [No Abstract]   [Full Text] [Related]  

  • 11. Consolidative 32P after second-look laparotomy for ovarian carcinoma.
    Condra KS; Mendenhall WM; Morgan LS; Marcus RB
    Radiat Oncol Investig; 1998; 6(2):97-102. PubMed ID: 9572686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 32P following negative second-look laparotomy for epithelial ovarian cancer.
    Rogers L; Varia M; Halle J; Freddo J; Qaqish B; O'Keefe T; Fowler W
    Gynecol Oncol; 1993 Aug; 50(2):141-6. PubMed ID: 8375727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of ovarian carcinoma.
    Stehman FB; Ehrlich CE
    J Indiana State Med Assoc; 1982 Oct; 75(10):714-8, 733. PubMed ID: 7142730
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intraperitoneal irradiation in limited epithelial neoplasms of the ovary. Review of the literature].
    Wolff JP; Burini GA
    Minerva Ginecol; 1985; 37(7-8):407-13. PubMed ID: 3906441
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of intraperitoneal implants in mice using 32P or 60Co.
    Shaeffer J; El-Mahdi AM; Peeples WJ; Constable WC
    Int J Nucl Med Biol; 1977 Jan; 4(1):77-9. PubMed ID: 266485
    [No Abstract]   [Full Text] [Related]  

  • 16. Possibilities of metabolic endoradiotherapy with P32 in the prevention of osseous metastases from breast neoplasms. Note II.
    Laconi A; Failla E; Melfi F
    Minerva Med; 1976 Feb; 67(8):498-501. PubMed ID: 1256697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian metastasis in endometrial carcinoma.
    Takeshima N; Hirai Y; Yano K; Tanaka N; Yamauchi K; Hasumi K
    Gynecol Oncol; 1998 Aug; 70(2):183-7. PubMed ID: 9740687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous regression in recurrent epithelial ovarian cancer.
    Fujiwaki R; Sawada K
    Arch Gynecol Obstet; 2007 May; 275(5):389-91. PubMed ID: 17177031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective irradiation for the treatment of recurrent ovarian carcinoma involving the vagina or rectum.
    Firat S; Erickson B
    Gynecol Oncol; 2001 Feb; 80(2):213-20. PubMed ID: 11161862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Accumulation of radioactive P32 by lung tumor tissue].
    Krishtafovich AA; Ermolova TP
    Vopr Onkol; 1974; 20(1):99-100. PubMed ID: 4439768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.